Exhibit 99.2

Medical Properties Trust
THIRD QUARTER 2016
Supplemental Information

MEDICALPROPERTIESTRUST.COM
TABLE OF CONTENTS
COMPANY OVERVIEW
Company Information 3
FINANCIAL INFORMATION
Reconciliation of Net Income to Funds from Operations 5
Debt Summary 6
Debt Maturity Schedule 7
Pro Forma Net Debt /Annualized EBITDA 8
PORTFOLIO INFORMATION
Lease and Mortgage Loan Maturity Schedule 9
Investments and Revenue by Asset Type, Operator, State and Country 10
EBITDAR to Rent Coverage 13
Summary of Acquisitions and Development Projects 14
FINANCIAL STATEMENTS
Consolidated Statements of Income 15
Consolidated Balance Sheets 16
Other Income Generating Assets 17
FORWARD-LOOKING STATEMENT Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results of the Company or future events to differ materially from those expressed in or underlying such forward-looking statements, including without limitation: Normalized FFO per share; expected payout ratio, the amount of acquisitions of healthcare real estate, if any; estimated debt metrics, portfolio diversification, capital markets conditions, the repayment of debt arrangements; statements concerning the additional income to the Company as a result of ownership interests in certain hospital operations and the timing of such income; the payment of future dividends, if any; completion of additional debt arrangement, and additional investments; national and international economic, business, real estate and other market conditions; the competitive environment in which the Company operates; the execution of the Company’s business plan; financing risks; the Company’s ability to maintain its status as a REIT for income tax purposes; acquisition and development risks; potential environmental and other liabilities; and other factors affecting the real estate industry generally or healthcare real estate in particular. For further discussion of the factors that could affect outcomes, please refer to the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2015, and as updated by the Company’s subsequently filed Quarterly Reports on Form 10-Q and other SEC filings. Except as otherwise required by the federal securities laws, the Company undertakes no obligation to update the information in this report.
On the Cover and Above: Saint Elizabeth’s Medical Center (Steward Health Care) - Brighton, Massachusetts. Acquired in 2016.
Q3 2016 | SUPPLEMENTAL INFORMATION 2

MEDICALPROPERTIESTRUST.COM
COMPANY OVERVIEW
MPT
Medical Properties Trust, Inc. is a Birmingham, Alabama based self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT’s financing model allows hospitals and other healthcare facilities to unlock the value of their underlying real estate in order to fund facility improvements, technology upgrades, staff additions and new construction. Facilities include acute care hospitals, inpatient rehabilitation hospitals, long-term acute care hospitals, and other medical and surgical facilities.
OFFICERS
Edward K. Aldag, Jr. Chairman, President and Chief Executive Officer
R. Steven Hamner Executive Vice President and Chief Financial Officer
Emmett E. McLean Executive Vice President, Chief Operating Officer, Treasurer and Secretary
J. Kevin Hanna Vice President, Controller and Chief Accounting Officer
BOARD OF DIRECTORS
Edward K. Aldag, Jr.
G. Steven Dawson
R. Steven Hamner
Robert. E. Holmes, Ph.D.
Sherry A. Kellett
William G. McKenzie
D. Paul Sparks, Jr.
Michael G. Stewart
C. Reynolds Thompson, III
CORPORATE HEADQUARTERS
Medical Properties Trust, Inc.
1000 Urban Center Drive, Suite 501
Birmingham, AL 35242
(205) 969-3755
(205) 969-3756 (fax)
www.medicalpropertiestrust.com
MPT Medical Properties
MPT Officers, from left: J. Kevin Hanna, Emmett E. McLean, Edward K. Aldag, Jr., and R. Steven Hamner.
Q3 2016 | SUPPLEMENTAL INFORMATION 3

MEDICALPROPERTIESTRUST.COM
COMPANY OVERVIEW(continued)
INVESTOR RELATIONS MPW CAPITAL MARKETS
Tim Berryman LISTED Director - Investor Relations
Charles Lambert Managing Director - Capital Markets (205) 397-8897
(205) 397-8589
tberryman@medicalpropertiestrust.com
NYSE clambert@medicalpropertiestrust.com
TRANSFER AGENT
American Stock Transfer and Trust Company 6201 15th Avenue Brooklyn, NY 11219
STOCK EXCHANGE LISTING AND TRADING SYMBOL
New York Stock Exchange (NYSE): MPW
SENIOR UNSECURED
DEBT RATINGS
Moody’s – Ba1 Standard & Poor’s – BBB-
HIGHER
INTENSITY OF CARE
LOWER
ACUTE CARE HOSPITALS
LONG- TERM ACUTE CARE HOSPITALS
INPATIENT REHABILITATION FACILITIES
NURSING HOMES
ASSISTED LIVING
HOME HEALTH CARE
CONTINUUM OF CARE
MEDICAL PROPERTIES TRUST FOCUSES ON THE MOST CRITICAL COMPONENTS OF HEALTHCARE DELIVERY.
ACUTE CARE HOSPITALS & FREE STANDING EMERGENCY ROOMS
LONG-TERM ACUTE CARE HOSPITALS
INPATIENT REHABILITATION FACILITIES
NURSING HOMES
ASSISTED LIVING
HOME HEALTH CARE
MPT facility types shown in green.
Q3 2016 | SUPPLEMENTAL INFORMATION 4

MEDICALPROPERTIESTRUST.COM
FINANCIAL INFORMATION
RECONCILIATION OF NET INCOME TO FUNDS FROM OPERATIONS
(Unaudited)
(Amounts in thousands except per share data)
For the Three Months Ended For the Nine Months Ended
September 30, 2016 September 30, 2015 September 30, 2016 September 30, 2015
FFO INFORMATION:
Net income attributable to MPT common stockholders $70,358 $23,057 $182,009 $81,361
Participating securities’ share in earnings (154) (265) (430) (781)
Net income, less participating securities’ share in earnings $70,204 $22,792 $181,579 $80,580
Depreciation and amortization(A) 24,374 20,016 69,181 49,728
Gain on sale of real estate (44,515) (3,268) (67,168) (3,268)
Funds from operations $50,063 $39,540 $183,592 $127,040
Write-off straight line rent and other - 3,928 3,063 3,928
Transaction costs from non-real estate dispositions (101) - 5,874 -
Acquisition expenses(A) 2,689 24,949 11,723 56,997
Impairment charges (80) - 7,295 -
Unutilized financing fees / debt refinancing costs 22,535 4,080 22,539 4,319
Normalized funds from operations $75,106 $72,497 $234,086 $192,284
Share-based compensation 2,322 2,515 5,831 7,716
Debt costs amortization 1,902 1,523 5,799 4,294
Additional rent received in advance(B) (300) (300) (900) (900)
Straight-line rent revenue and other (11,733) (9,840) (33,766) (23,100)
Adjusted funds from operations $67,297 $66,395 $211,050 $180,294
PER DILUTED SHARE DATA:
Net income, less participating securities’ share in earnings $0.28 $0.10 $0.75 $0.38
Depreciation and amortization(A) 0.10 0.09 0.29 0.23
Gain on sale of real estate (0.18) (0.01) (0.28) (0.01)
Funds from operations $0.20 $0.18 $0.76 $0.60
Write-off straight line rent and other - 0.01 0.01 0.02
Transaction costs from non-real estate dispositions - - 0.03 -
Acquisition expenses(A) 0.01 0.11 0.05 0.27
Impairment charges - - 0.03 -
Unutilized financing fees / debt refinancing costs 0.09 0.02 0.09 0.02
Normalized funds from operations $0.30 $0.32 $0.97 $0.91
Share-based compensation 0.01 0.01 0.02 0.04
Debt costs amortization 0.01 0.01 0.02 0.01
Additional rent received in advance(B) - - - -
Straight-line rent revenue and other (0.05) (0.04) (0.14) (0.11)
Adjusted funds from operations $0.27 $0.30 $0.87 $0.85
(A) Includes our share of real estate depreciation and acquisition expenses from unconsolidated joint ventures (if any). Any such amounts are included with the activity of all of our equity interests in the “Other income (expense)” line on the consolidated statements of income.
(B) Represents additional rent received from one tenant in advance of when we can recognize as revenue for accounting purposes. This additional rent is being recorded to revenue on a straight-line basis over the lease life.
Investors and analysts following the real estate industry utilize funds from operations, or FFO, as a supplemental performance measure. FFO, reflecting the assumption that real estate asset values rise or fall with market conditions, principally adjusts for the effects of GAAP depreciation and amortization of real estate assets, which assumes that the value of real estate diminishes predictably over time. We compute FFO in accordance with the definition provided by the National Association of Real Estate Investment Trusts, or NAREIT, which represents net income (loss) (computed in accordance with GAAP), excluding gains (losses) on sales of real estate and impairment charges on real estate assets, plus real estate depreciation and amortization and after adjustments for unconsolidated partnerships and joint ventures.
In addition to presenting FFO in accordance with the NAREIT definition, we also disclose normalized FFO, which adjusts FFO for items that relate to unanticipated or non-core events or activities or accounting changes that, if not noted, would make comparison to prior period results and market expectations less meaningful to investors and analysts. We believe that the use of FFO, combined with the required GAAP presentations, improves the understanding of our operating results among investors and the use of normalized FFO makes comparisons of our operating results with prior periods and other companies more meaningful. While FFO and normalized FFO are relevant and widely used supplemental measures of operating and financial performance of REITs, they should not be viewed as a substitute measure of our operating performance since the measures do not reflect either depreciation and amortization costs or the level of capital expenditures and leasing costs necessary to maintain the operating performance of our properties, which can be significant economic costs that could materially impact our results of operations. FFO and normalized FFO should not be considered an alternative to net income (loss) (computed in accordance with GAAP) as indicators of our financial performance or to cash flow from operating activities (computed in accordance with GAAP) as an indicator of our liquidity.
We calculate adjusted funds from operations, or AFFO, by subtracting from or adding to normalized FFO (i) unbilled rent revenue, (ii) non-cash share-based compensation expense, and (iii) amortization of deferred financing costs. AFFO is an operating measurement that we use to analyze our results of operations based on the receipt, rather than the accrual, of our rental revenue and on certain other adjustments. We believe that this is an important measurement because our leases generally have significant contractual escalations of base rents and therefore result in recognition of rental income that is not collected until future periods, and costs that are deferred or are non-cash charges. Our calculation of AFFO may not be comparable to AFFO or similarly titled measures reported by other REITs. AFFO should not be considered as an alternative to net income (calculated pursuant to GAAP) as an indicator of our results of operations or to cash flow from operating activities (calculated pursuant to GAAP) as an indicator of our liquidity.
Q3 2016 | SUPPLEMENTAL INFORMATION 5

MEDICALPROPERTIESTRUST.COM
FINANCIAL INFORMATION
DEBT SUMMARY
(as of September 30, 2016)
($ amounts in thousands)
Debt Instrument Rate Type Rate Balance
2016 Unsecured Notes Fixed 5.68% (A) $60,000
Northland – Mortgage Capital Term Loan Fixed 6.20% 13,179
2018 Credit Facility Revolver Variable 1.87% (B) -
2019 Term Loan Variable 2.18% 250,000
5.750% Notes Due 2020 (Euro) (C) Fixed 5.75% 224,700
4.000% Notes Due 2022 (Euro) (C) Fixed 4.00% 561,750
6.375% Notes Due 2022 Fixed 6.38% 350,000
6.375% Notes Due 2024 Fixed 6.38% 500,000
5.500% Notes Due 2024 Fixed 5.50% 300,000
5.250% Notes Due 2026 Fixed 5.25% 500,000
$2,759,629
Debt premium 1,902
Debt issuance costs (32,982)
Weighted average rate 5.15% $2,728,549
Rate Type as Percentage of Total Debt
Variable 9.1%
Fixed 90.9%
(A) Represents the weighted-average rate for three tranches of the Notes at September 30, 2016, factoring in interest rate swaps in effect at that time. The Notes were repaid on October 31, 2016.
(B) At September 30, 2016, this represents a $1.3 billion unsecured revolving credit facility with spreads over LIBOR ranging from 0.95% to 1.75%.
(C) Represents 700 million of bonds issued in Euros and converted to U.S. dollars at September 30, 2016.
Q3 2016 | SUPPLEMENTAL INFORMATION 6

MEDICALPROPERTIESTRUST.COM
FINANCIAL INFORMATION
DEBT MATURITY SCHEDULE
(as of September 30, 2016)
($ amounts in thousands)
Debt Instrument 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
2016 Unsecured Notes (A) $60,000 $- $- $- $- $- $- $- $- $- $-
Northland – Mortgage Capital Term Loan 78 320 12,781 - - - - - - - -
2018 Credit Facility Revolver - - - - - - - - - - -
2019 Term Loan - - - 250,000 - - - - - - -
5.750% Notes Due 2020 (Euro) - - - - 224,700 - - - - - -
4.000% Notes Due 2022 (Euro) - - - - - - 561,750 - - - -
6.375% Notes Due 2022 - - - - - - 350,000 - - - -
6.375% Notes Due 2024 - - - - - - - - 500,000 - -
5.500% Notes Due 2024 - - - - - - - - 300,000 - -
5.250% Notes Due 2026 - - - - - - - - - - 500,000
$60,078 $320 $12,781 $250,000 $224,700 $- $911,750 $- $800,000 $- $500,000
$1,000,000 $900,000 $800,000 $700,000 $600,000 $500,000 $400,000 $300,000 $200,000 $100,000 $911,750
$- $60,078 $320 $12,781 $250,000 $224,700 $911,750 $800,000 $500,000
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
2016 Unsecured Notes (A) Northland – Mortgage Capital Term Loan 2018 Credit Facility Revolver 2019 Term Loan
5.750% Notes Due 2020 (Euro) 4.000% Notes Due 2022 (Euro) 6.375% Notes Due 2022 6.375% Notes Due 2024
5.500% Notes Due 2024 5.250% Notes Due 2026
(A) The Notes were repaid on October 31, 2016.
Q3 2016 | SUPPLEMENTAL INFORMATION 7

MEDICALPROPERTIESTRUST.COM
FINANCIAL INFORMATION
PRO FORMA NET DEBT / ANNUALIZED EBITDA
(Unaudited)
(Amounts in thousands) For the Three Months Ended
September 30, 2016
Net income attributable to MPT common stockholders $70,358
Pro forma adjustments for capital transactions and acquisitions that occurred after the period (A) 33,725
Pro forma net income $104,083
Add back:
Interest expense 40,262
Debt refinancing costs 22,535
Depreciation and amortization 25,048
Stock-based compensation 2,322
Mid-quarter acquisitions / divestitures 701
Gain on sale of real estate and other asset dispositions, net (44,616)
Impairment and other charges (80)
Acquisition expenses 2,689
Income tax expense 490
3Q 2016 Pro forma EBITDA $153,434
Annualization $613,736
Total debt $2,728,549
Pro forma changes to debt balance after September 30, 2016 (A) 609,320
Cash (190,237)
Net debt $3,147,632
Net debt / pro forma annualized EBITDA 5.1x
(A) Reflects impact from previously disclosed investments, including the Steward transaction, two RCCH facilities and 29 facilities in Germany.
Q3 2016 | SUPPLEMENTAL INFORMATION 8

MEDICALPROPERTIESTRUST.COM
PORTFOLIO INFORMATION
LEASE AND MORTGAGE LOAN MATURITY SCHEDULE
(as of September 30, 2016)
($ amounts in thousands)
Years of Maturities (A) (B) Total Leases/Loans Base Rent/Interest (C) Percent of Total Base Rent/Interest
2016 - $- -
2017 - - -
2018 1 2,016 0.3%
2019 2 5,017 0.9%
2020 5 10,662 1.9%
2021 3 13,125 2.4%
2022 15 72,532 13.0%
2023 4 12,630 2.3%
2024 1 2,237 0.4%
2025 7 21,927 3.9%
Thereafter 190 417,682
228 $557,828 100.0%
Percentage of Total Base Rent/Interest
80% 74.9%
70% 50% 40% 30% 20% 10% 0%
0.0% 0.0% 0.3% 0.9% 1.9% 2.4% 13.0% 2.3% 0.4% 3.9% 74.9%
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Thereafter
(A) Excludes 11 of our facilities that are under development, our Twelve Oaks facility that is not fully occupied, and the 9 properties that we own through joint venture arrangements. In addition, the schedule reflects post September 30, 2016 transactions and commitments, including the Steward transaction, the acquisition of two RCCH facilities and 29 facilities in Germany.
(B) Lease/Loan expiration is based on the fixed term of the lease/loan and does not factor in potential renewal options provided for in our agreements.
(C) Represents base rent/interest income on an annualized basis but does not include tenant recoveries, additional rents and other lease-related adjustments to revenue (i.e., straight-line rents and deferred revenues).
Q3 2016 | SUPPLEMENTAL INFORMATION 9

MEDICALPROPERTIESTRUST.COM
PORTFOLIO INFORMATION
INVESTMENTS AND REVENUE BY ASSET TYPE
(September 30, 2016)
($ amounts in thousands)

(A) Includes three medical office buildings.
(B) Represents investment concentration as a percentage of gross real estate assets, other loans, and equity investments assuming all
real estate commitments, such as the Steward acquisition, are fully funded.
Q3 2016 SUPPLEMENTAL INFORMATION 10

MEDICALPROPERTIESTRUST.COM
PORTFOLIO INFORMATION
INVESTMENTS AND REVENUE BY OPERATOR
(September 30, 2016)
($ amounts in thousands)

(A) Represents investment concentration as a percentage of gross real estate assets, other loans, and equity investments assuming all real estate commitments, such as the Steward acquisition, are fully funded.
(B) Closed on facilities subsequent to September 30, 2016.

Q3 2016 | SUPPLEMENTAL INFORMATION    11

MEDICALPROPERTIESTRUST.COM
PORTFOLIO INFORMATION
INVESTMENTS AND REVENUE BY U.S. STATE AND COUNTRY
(September 30, 2016)
($ amounts in thousands)
U.S. States and Other Countries Total Gross Assets Percentage of Gross Assets YTD Revenue Percentage of Total Revenue
Massachusetts $ 1,250,000 17.3% $ — —
Texas 944,028 13.1% 72,811 18.8%
California 542,892 7.5% 49,724 12.8%
New Jersey 447,570 6.2% 28,398 7.3%
Arizona 329,602 4.6% 17,678 4.6%
25 Other States 1,892,229 26.2% 143,289 36.9%
Other assets (A) 251,587 3.5% — —
United States $ 5,657,908 78.4% $ 311,900 80.4%
Germany $ 1,376,626 19.1% $ 72,718 18.8%
Italy(A) 94,569 1.3% — —
United Kingdom 36,646 0.5% 2,985 0.7%
Spain(A) 25,011 0.3% 251 0.1%
Other assets(A) 27,017 0.4% — —
International $ 1,559,869 21.6% $ 75,954 19.6%
Total $ 7,217,777 (B) 100.0% $ 387,854 100.0%
(A) Includes our equity investments, of which related income is reflected in other income in our income statement.
(B) Represents investment concentration as a percentage of gross real estate assets, other loans, and equity investments assuming all real estate commitments, such as the Steward acquisition, are fully funded.
Investments by Country
1.3% 0.5% 0.3% 0.4%
19.1% 78.4%
Investments by U.S. State
3.5%
17.3%
26.2%
13.1%
4.6% 6.2% 7.5%
United States
Germany
Italy(A)
United Kingdom
Spain(A)
Other assets(A)
Massachusetts
Texas
California
New Jersey
Arizona
25 Other States
Other assets(A)
Revenue by Country
0.7% 0.1%
18.8%
80.4%
Revenue by U.S. State
18.8%
36.9%
12.8%
4.6% 7.3%
Q3 2016 | SUPPLEMENTAL INFORMATION 12

MEDICALPROPERTIESTRUST.COM
PORTFOLIO INFORMATION
Same Store EBITDAR(1) Rent Coverage
YOY and Sequential Quarter Comparisons by Property Type

Q2 2015 (YoY)    Q2 2016 (YoY) Q1 2016 (QoQ)Q2 2016 (QoQ)
Stratification of Portfolio EBITDAR Rent Coverage

Notes:
Same Store represents properties with at least 24 months of financial reporting data. Properties that do not provide financial reporting and disposed assets are not included.
Freestanding ERs will be reported as a distinct property type when 24 months of financial reporting data is available for a property or all properties associated with a funding commitment as applicable.
All data presented is on a trailing twelve month basis.
(1) EBITDAR adjusted for non-recurring items.
Q3 2016      SUPPLEMENTAL INFORMATION
13

MEDICALPROPERTIESTRUST.COM
PORTFOLIO INFORMATION
SUMMARY OF COMPLETED ACQUISITIONS / DEVELOPMENT PROJECTS AS OF SEPTEMBER 30, 2016
($ amounts in thousands)

SUMMARY OF CURRENT INVESTMENT COMMITMENTS AS OF SEPTEMBER 30, 2016
($ amounts in thousands)

SUMMARY OF CURRENT DEVELOPMENT PROJECTS AS OF SEPTEMBER 30, 2016
($ amounts in thousands)

Q3 2016 | SUPPLEMENTAL INFORMATION    14

MEDICALPROPERTIESTRUST.COM
FINANCIAL STATEMENTS
MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES
Consolidated Statements of Income
(Amounts in thousands except per share data)

Q3 2016 | SUPPLEMENTAL INFORMATION    15

MEDICALPROPERTIESTRUST.COM
FINANCIAL STATEMENTS
MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES
Consolidated Balance Sheets
(Amounts in thousands except per share data)

(A) Financials have been derived from the prior year audited financial statements.
Q3 2016      SUPPLEMENTAL INFORMATION 16

MEDICALPROPERTIESTRUST.COM
FINANCIAL STATEMENTS
OTHER INCOME GENERATING ASSETS AS OF SEPTEMBER 30, 2016
($ amounts in thousands)
Operator Investment Annual Interest Rate YTD RIDEA Income (A) Security / Credit Enhancements
Non-Operating Loans
Vibra Healthcare acquisition loan(B) $ 6,982 10.25%
Secured and cross-defaulted with real estate, other agreements and guaranteed by Parent
Alecto working capital 12,500 11.22%
Secured and cross-defaulted with real estate and guaranteed by Parent
IKJG/HUMC working capital 9,282 10.73%
Secured and cross-defaulted with real estate and guaranteed by Parent
Ernest Health 23,385 9.10%
Secured and cross-defaulted with real estate and guaranteed by Parent
Other 17,084
69,233
Operating Loans
Ernest Health (C) 93,200 15.00% $ 11,476
Secured and cross-defaulted with real estate and guaranteed by Parent
IKJG/HUMC convertible loan 3,352 161
Secured and cross-defaulted with real estate and guaranteed by Parent
96,552 11,637
Equity investments(D)
Domestic 9,199 579
International(E) 112,271 3,457 (F)
(A) Income earned on operating loans is reflected in the interest income line of the income statement.
(B) Original amortizing acquisition loan was $41 million; loan matures in 2019.
(C) Due to compounding, effective interest rate is 16.4%.
(D) All earnings in income from equity investments are reported on a one quarter lag basis.
(E) Includes equity investments in Spain, Italy, and Germany.
(F) Excludes our share of real estate depreciation and acquisition expenses of certain unconsolidated joint ventures.
Q3 2016 | SUPPLEMENTAL INFORMATION 17

MPT
Medical Properties Trust
1000 Urban Center Drive, Suite 501
Birmingham, AL 35242
(205) 969-3755 NYSE: MPW
www.medicalpropertiestrust.com
Contact:
Charles Lambert, Managing Director - Capital Markets
(205) 397-8897 or clambert@medicalpropertiestrust.com
or
Tim Berryman, Director - Investor Relations
(205) 397-8589 or tberryman@medicalpropertiestrust.com
AT THE VERY HEART OF HEALTHCARE® .